Article Versions Notes

Garrós N, Mallandrich M, Beirampour N, Mohammadi R, Domènech Ò, Rodríguez-Lagunas MJ, Clares B, Colom H. Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome. Pharmaceutics. 2022; 14(9):1895. https://doi.org/10.3390/pharmaceutics14091895

Garrós, Núria, Mireia Mallandrich, Negar Beirampour, Roya Mohammadi, Òscar Domènech, Maria José Rodríguez-Lagunas, Beatriz Clares, and Helena Colom. 2022. "Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome" Pharmaceutics 14, no. 9: 1895. https://doi.org/10.3390/pharmaceutics14091895

Garrós, N., Mallandrich, M., Beirampour, N., Mohammadi, R., Domènech, Ò., Rodríguez-Lagunas, M. J., Clares, B., & Colom, H. (2022). Baricitinib Liposomes as a New Approach for the Treatment of Sjögren’s Syndrome. Pharmaceutics, 14(9), 1895. https://doi.org/10.3390/pharmaceutics14091895